Kinfo
Angiodynamics Inc. logo

Angiodynamics Inc.

ANGONASDAQHealthcare·US · USD
$12.85
+0.08 (+0.59%)
Prices as of July 14, 2026 · live

Price

Key statistics

Valuation
Market cap527.85M USD
Enterprise value506.70M USD
Trailing P/E41.40
Forward P/E-58.70
PEG ratio0.57
Price / sales1.70
Price / book3.11
Profitability
Gross margin52.89%
Operating margin-8.20%
Profit margin-10.01%
Return on assets-4.68%
Return on equity-17.47%
Income (TTM)
Revenue313.72M USD
Gross profit170.34M USD
EBITDA17.81M USD
Net income-31.39M USD
Diluted EPS-$0.76
Rev. growth (YoY)8.90%
Balance sheet
Total cash37.81M USD
Total debt11.39M USD
Debt / equity6.57
Current ratio2.35
Book value / share$4.16
Cash flow (TTM)
Operating cash flow4.45M USD
Levered free cash flow13.94M USD
Shares & price
Shares outstanding41.68M
Float34.61M
Held by institutions94.69%
Beta0.34
50-day MA$11.90
200-day MA$11.56
52-week high$13.99
52-week low$8.36
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-04-02-0.110.02+118.18%2025-10-02-0.12-0.10+16.67%2025-09-090.330.33+0.00%2025-07-15-0.12-0.03+75.00%2025-04-02-0.130.03+123.08%
About Angiodynamics Inc.

AngioDynamics Inc. is a medical technology company that designs, manufactures, and sells medical, surgical, and diagnostic devices for treating peripheral vascular disease, oncology, and surgical applications in the United States and internationally. The company focuses on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving patient quality of life through innovative minimally invasive solutions. Key products include the Auryon Atherectomy system, which uses optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium, and the AlphaVac mechanical thrombectomy system for emergent aspiration in thrombus management. Its portfolio also encompasses ablation systems, fluid management systems, vascular access products, angiographic devices, drainage solutions, thrombolytics, and venous products. Operating through Med Tech and Med Device segments, AngioDynamics Inc. supports healthcare professionals worldwide with facilities in North America, Europe, APAC, the Middle East, and South America. Founded in 1988 and headquartered in Latham, New York, it remains a key player in the medical devices sector serving peripheral vascular and oncology needs.

Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Mr. James C. Clemmer
Employees
675
Headquarters
Latham, NY, United States

Frequently asked questions about Angiodynamics Inc.